Labcorp (LH) Sets Q4 2025 Earnings Release Date for Feb 17, 2026
LABCORP HOLDINGS INC.
Subscribe to track LH
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Labcorp (LH) Announces Q4 2025 Earnings Date
Company: LABCORP HOLDINGS INC. (LH) Form: 8-K | Filed: 2026-01-15 Significance: Low
Announcement: • Event: Q4 2025 Financial Results Release & Conference Call • Date: February 17, 2026 • Time: Before market open, with a call at 9 a.m. ET
Key Insight: This is a routine administrative filing announcing the date for an upcoming earnings report. It contains no new financial data or insider transactions.
Market Context: As a large-cap company ($22.13B), such announcements are standard procedure and generally do not impact the stock price. Market attention will shift to the actual results on Feb 17.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: LABCORP HOLDINGS INC. (LH)
Executive Summary
- Trading Significance: Low
- Key Takeaway: This Form 8-K is a routine administrative announcement from Labcorp, setting the date for its fourth-quarter 2025 earnings release. It does not contain any financial results or insider trading activity.
- Market Impact: Neutral. This type of filing is standard corporate procedure and is not expected to influence trading activity.
Company Information
| Field | Value |
|---|---|
| Company | LABCORP HOLDINGS INC. |
| Ticker Symbol | LH |
| CIK | 0000920148 |
| Industry | Medical Laboratories |
Filing Details
| Field | Value |
|---|---|
| Form Type | 8-K |
| Filing Date | 2026-01-15 |
| Event Date | 2026-01-15 |
| Description | Item 7.01 Regulation FD Disclosure: Announcement of date for earnings release. |
Financial Impact Assessment
This filing does not report a financial transaction. It is a non-event from a trading perspective, simply providing the date for a future material event (the earnings release).
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Shares Transacted | 0 |
| % of Shares Outstanding | 0.00% |
| Materiality Assessment | Not Applicable |
Impact Evaluation
- Market Cap Context: For a company with a market capitalization of $22.13 billion, this administrative filing is immaterial.
- Significance: The filing's significance is low as it only serves to inform the market of the timing for the Q4 2025 earnings release on February 17, 2026.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The filing provides no new information that would alter the market's valuation of the company. It is a standard, expected announcement.
Volume & Sentiment
- Expected Volume Impact: None. Trading volume is not expected to be affected by this news.
- Sentiment Indicator: Neutral. The filing confirms the company is following standard reporting procedures.
Key Takeaways
- Routine Filing: Labcorp filed a Form 8-K to announce its Q4 2025 earnings release date.
- Event Date: The earnings will be released before the market opens on Tuesday, February 17, 2026.
- No Market-Moving Info: The filing itself is procedural and contains no data that would typically influence investor decisions.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.